Stock INAB IN8BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart IN8bio, Inc.

Equities

INAB

US45674E1091

Market Closed - Nasdaq
Other stock markets
 01:30:00 06/06/2024 am IST 		5-day change 1st Jan Change
1.37 USD +11.38% Intraday chart for IN8bio, Inc. +34.31% -0.72%
03/06 IN8bio, Inc. Presents Progression-Free Survival Update from Phase 1 Study of INB-200 At 2024 American Society of Clinical Oncology Annual Meeting CI
24/05 IN8bio Plans to Report Improvement in Progression-Free Survival of Newly Diagnosed Patients With Glioblastoma Multiforme MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
IN8BIO, INC. Stock IN8bio, Inc.
 54.27M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.01B -
ARGENX SE Stock argenx SE
 22.59B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. INAB Stock
  4. Charts IN8bio, Inc.
  5. Sector Chart